Gold-Coated Iron Oxide Nanoparticles as a T 2 Contrast Agent in Magnetic Resonance Imaging
Authors: Ahmad, Tanveer; Bae, Hongsub; Rhee, Ilsu; Chang, Yongmin; Jin, Seong-Uk; Hong, Sungwook
Source: Journal of Nanoscience and Nanotechnology, Volume 12, Number 7, July 2012 , pp. 5132-5137(6)
Publisher: American Scientific Publishers
Abstract:Gold-coated iron oxide (Fe3O4) nanoparticles were synthesized for use as a T 2 contrast agent in magnetic resonance imaging (MRI). The coated nanoparticles were spherical in shape with an average diameter of 20 nm. The gold shell was about 2 nm thick. The bonding status of the gold on the nanoparticle surfaces was checked using a Fourier transform infrared spectrometer (FTIR). The FTIR spectra confirmed the attachment of homocysteine, in the form of thiolates, to the Au shell of the Au-Fe3O4 nanoparticles. The relaxivity ratio, R 2/R 1, for the coated nanoparticles was 3-fold higher than that of a commercial contrast agent, Resovist, which showed the potential for their use as a T 2 contrast agent with high efficacy. In animal experiments, the presence of the nanoparticles in rat liver resulted in a 71% decrease in signal intensity in T 2-weighted MR images, indicating that our gold-coated iron oxide nanoparticles are suitable for use as a T 2 contrast agent in MRI.
Document Type: Research Article
Publication date: July 1, 2012
- Journal for Nanoscience and Nanotechnology (JNN) is an international and multidisciplinary peer-reviewed journal with a wide-ranging coverage, consolidating research activities in all areas of nanoscience and nanotechnology into a single and unique reference source. JNN is the first cross-disciplinary journal to publish original full research articles, rapid communications of important new scientific and technological findings, timely state-of-the-art reviews with author's photo and short biography, and current research news encompassing the fundamental and applied research in all disciplines of science, engineering and medicine.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Terms & Conditions
- ingentaconnect is not responsible for the content or availability of external websites